BioSpace News Archive

DermTech’s Late Breaking Abstract Presented at AAD Validates Gene Expression Against High Risk DNA Mutations Providing Objective Information for the Diagnosis of Melanoma

The data provides the foundation for launching Nevome, DermTech’s second “adhesive patch skin biopsy” product, to help assess pigmented lesions suspicious for melanoma.

February 17, 2018
·
2 min read
Drug Development

AbbVie Presents New Phase 2b Data on Upadacitinib in Atopic Dermatitis

AbbVie today presented new positive results from a Phase 2b dose-ranging study evaluating upadacitinib, an investigational, once-daily oral JAK1-selective inhibitor, in adult patients with moderate to severe atopic dermatitis.

February 17, 2018
·
10 min read
Drug Development

AbbVie Presents New Positive Late-Breaking Data from Two Phase 3 Psoriasis Trials of Risankizumab at the 2018 American Academy of Dermatology Annual Meeting

AbbVie presented today new positive results from the pivotal Phase 3 ultIMMa-1 and ultIMMa-2 replicate clinical trials that evaluated the safety and efficacy of risankizumab (150 mg) compared to placebo or ustekinumab (45 or 90 mg, based on patient weight).

February 17, 2018
·
11 min read
Drug Development

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers

RELIEF™ trial demonstrated statistically significant reductions in oral ulcers with apremilast 30 mg versus placebo through week 12.

February 17, 2018
·
10 min read